Effect of routine repeat transurethral resection for superficial bladder cancer: A long-term observational study

Journal of Urology

Volumn 170, Issue 2 I, 2003, Pages 433-437

  Grimm, Marc Oliver ^a   Steinhoff, Christine ^a,b   Simon, Xenia ^a   Spiegelhalder, Philipp ^a   Ackermann, Rolf ^a   Vögeli, Thomas Alexander ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b MAX PLANCK INSTITUTE FOR MOLECULAR GENETICS   (Germany)

Author keywords

Bladder; Bladder neoplasms; Outcome; Progression; Recurrence; Transurethral resection; Urethra

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER INVASION; CANCER RECURRENCE; COHORT ANALYSIS; CYSTECTOMY; FEMALE; GERMANY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECURRENCE RISK; SUPERFICIAL CANCER; TRANSURETHRAL RESECTION; TREATMENT OUTCOME;

EID: 0038152768     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ju.0000070437.14275.e0     Document Type: Article

References (20)

1. Klän, R., Loy, V. and Huland, H.: Residual tumor discovered in routine second transurethral resection in patients with stage T1 transitional cell carcinoma of the bladder. J Urol, 146: 316, 1991
2. Köhrmann, K. U., Woeste, M., Kappes, J. and Alken, P.: Der Wert der transurethralen Nachresektion beim oberflächlichen Harnblasenkarzinom. Akt Urol, 25: 208, 1994
3. Mersdorf, A., Brauers, A., Wolff, J. M., Schneider, V. and Jakse, G.: 2nd TUR for superficial bladder cancer: a must? J Urol, suppl., 159: 143, abstract 542, 1998
4. Herr, H. W.: The value of a second transurethral resection in evaluating patients with bladder tumors. J Urol, 162: 74, 1999
5. Kurth, K. H., Bouffioux, C., Sylvester, R., van der Meijden, A. P., Oosterlinck, W. and Brausi, M.: Treatment of superficial bladder tumors: achievements and needs. The EORTC Genitourinary Group. Eur Urol, 37: 1, 2000
6. Bouffioux, Ch., Kurth, K. H., Bono, A., Oosterlinck, W., Boeken Kruger, C., De Pauw, M. et al: Intravesical adjuvant chemotherapy for superficial transitional cell bladder carcinoma: results of 2 European Organization for Research and Treatment of Cancer randomized trials with mitomycin C and doxorubicin comparing early versus delayed instillations and short-term versus long-term treatment. J Urol, 153: 934, 1995
7. Cookson, M. S., Herr, H. W., Zhang, Z.-F., Soloway, S., Sogani, P. C. and Fair, W. R.: The treated natural history of high risk superficial bladder cancer: 15-year outcome. J Urol, 158: 62, 1997
8. Schwaibold, H. E., Treiber, U., Kuebler, H., Leyh, H. and Hartung, R.: Second transurethral resection detects histopathological changes worsening the prognosis in 25% of patients with T1 bladder cancer. J Urol, suppl., 163: 153, abstract 680, 2000
9. Bressel, M., Kemper, K. and Stadtler, F.: Requirements and technique of transurethral electroresection of bladder carcinoma. Urologe, 8: 73, 1969
10. Sidransky, D., Frost, P., von Eschenbach, A., Oyasu, R., Preisinger, A. C. and Vogelstein, B.: Clonal origin bladder cancer. N Engl J Med, 326: 737, 1992
11. Habuchi, T., Takahashi, R., Yamada, H., Kakehi, Y., Sugiyama, T. and Yoshida, O.: Metachronous multifocal development of urothelial cancers by intraluminal seeding. Lancet, 342: 1087, 1993
12. Millan-Rodriguez, F., Chechile-Toniolo, G., Salvador-Bayarri, J., Palou, J. and Vicente-Rodriguez, J.: Multivariate analysis of the prognostic factors of primary superficial bladder cancer. J Urol, 163: 73, 2000
13. Oosterlinck, W., Kurth, K. H., Schröder, F., Bultinck, J., Hammond, B., Sylvester, R. et al: A prospective European Organization for Research and Treatment of Cancer Genitourinary Group randomized trial comparing transurethral resection followed by a single intravesical instillation of epirubicin or water in single stage Ta, T1 papillary carcinoma of the bladder. J Urol, 149: 749, 1993
14. The effect of intravesical thiotepa on tumour recurrence after endoscopic treatment of newly diagnosed superficial bladder cancer. A further report with long-term follow-up of a Medical Research Council randomized trial. Medical Research Council Working Party on Urological Cancer, Subgroup on Superficial Bladder Cancer. Br J Urol, 73: 632, 1994
15. Tolley, D. A., Parmar, M. K. B., Grigor, K. M., Lallemand, G. and the Medical Research Council Superficial Bladder Cancer Working Party: The effect of intravesical mitomycin C on recurrence of newly diagnosed superficial bladder cancer: a further report with 7 years of followup. J Urol, 155: 1233, 1996
16. Krege, S., Giani, G., Meyer, R., Otto, T., Rübben, H. and Participating Clinics: A randomized multicenter trial of adjuvant therapy in superficial bladder cancer: transurethral resection only versus transurethral resection plus mitomycin C versus transurethral resection plus bacillus Calmette-Guerin. J Urol, 156: 962, 1996
17. Flamm, J., Donner, G., Oberleitner, S., Hausmann, R. and Havelec, L.: Adjuvant intravesical mitoxantrone after transurethral resection of primary superficial transitional cell carcinoma of the bladder. A prospective randomised study. Eur J Cancer, 31: 143, 1995
18. Pawinski, A., Sylvester, R., Kurth, K. H., Bouffioux, C., Van Der Meijden, A., Parmar, M. K. B. et al: A combined analysis of European Organization for Research and Treatment of Cancer, and Medical Research Council randomized clinical trials for the prophylactic treatment of stage TaT1 bladder cancer. J Urol, 156: 1934, 1996
19. Kurth, K., Tunn, U., Ay, R., Schröder, F. H., Pavone-Macaluso, M., Debruyne, F. et al: Adjuvant chemotherapy for superficial transitional cell bladder carcinoma: long-term results of a European Organization for Research and Treatment of Cancer randomized trial comparing doxorubicin, ethoglucid and transurethral resection alone. J Urol, 158: 378, 1997
20. Brauers, A., Buettner, R. and Jakse, G.: Second resection and prognosis of primary high risk superficial bladder cancer: is cystectomy often too early? J Urol, 165: 808, 2001